Your browser doesn't support javascript.
loading
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
Muranen, Taru A; Morra, Anna; Khan, Sofia; Barnes, Daniel R; Bolla, Manjeet K; Dennis, Joe; Keeman, Renske; Leslie, Goska; Parsons, Michael T; Wang, Qin; Ahearn, Thomas U; Aittomäki, Kristiina; Andrulis, Irene L; Arun, Banu K; Behrens, Sabine; Bialkowska, Katarzyna; Bojesen, Stig E; Camp, Nicola J; Chang-Claude, Jenny; Czene, Kamila; Devilee, Peter; Domchek, Susan M; Dunning, Alison M; Engel, Christoph; Evans, D Gareth; Gago-Dominguez, Manuela; García-Closas, Montserrat; Gerdes, Anne-Marie; Glendon, Gord; Guénel, Pascal; Hahnen, Eric; Hamann, Ute; Hanson, Helen; Hooning, Maartje J; Hoppe, Reiner; Izatt, Louise; Jakubowska, Anna; James, Paul A; Kristensen, Vessela N; Lalloo, Fiona; Lindeman, Geoffrey J; Mannermaa, Arto; Margolin, Sara; Neuhausen, Susan L; Newman, William G; Peterlongo, Paolo; Phillips, Kelly-Anne; Pujana, Miquel Angel; Rantala, Johanna; Rønlund, Karina.
Affiliation
  • Muranen TA; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. taru.a.muranen@helsinki.fi.
  • Morra A; Research Program in Systems Oncology, Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland. taru.a.muranen@helsinki.fi.
  • Khan S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Barnes DR; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Bolla MK; Department of Genetics, HUSLAB, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Dennis J; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
  • Keeman R; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Parsons MT; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ahearn TU; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Aittomäki K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Population Health Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Arun BK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Behrens S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Bialkowska K; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
  • Bojesen SE; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Camp NJ; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Chang-Claude J; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Czene K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Devilee P; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Domchek SM; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Dunning AM; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Engel C; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Evans DG; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Gago-Dominguez M; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • García-Closas M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Gerdes AM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
  • Glendon G; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Hahnen E; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Hamann U; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Hanson H; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Hooning MJ; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
  • Hoppe R; Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University Hospital Foundation NHS Trust, Manchester, UK.
  • Izatt L; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Jakubowska A; Clinical Genetics Service, Manchester Centre for Genomic Medicine, Manchester University Hospitals Foundation Trust, Manchester, UK.
  • James PA; Manchester Breast Centre, Oglesby Cancer Research Centre, The Christie, University of Manchester, Manchester, UK.
  • Kristensen VN; Health Research Institute of Santiago de Compostela Foundation (FIDIS), SERGAS, Cancer Genetics and Epidemiology Group Santiago de Compostela, Santiago de Compostela, Spain.
  • Lalloo F; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Lindeman GJ; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Mannermaa A; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Margolin S; Team "Exposome and Heredity", CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France.
  • Neuhausen SL; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Newman WG; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Peterlongo P; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Phillips KA; SouthWest Thames Centre for Genomics, St George's University Hospital's NHS Foundation Trust, London, UK.
  • Pujana MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Rantala J; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Rønlund K; University of Tübingen, Tübingen, Germany.
NPJ Breast Cancer ; 9(1): 37, 2023 May 12.
Article in En | MEDLINE | ID: mdl-37173335
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: NPJ Breast Cancer Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: NPJ Breast Cancer Year: 2023 Document type: Article Affiliation country: Country of publication: